Drugs / Jarro-Dophilus
last change Jul 2008 re-read 3 minutes ago

Jarro-Dophilus

Developed for
Clostridium difficile colitis · diarrheal disease

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 3 NCT00506181 Comparator Jul 2007 → Jul 2008 Clostridium difficile colitis, diarrheal disease Hadassah Medical Organization Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Jarro-Dophilus “"Jarro-Dophilus" probiotic mixture (4,400,000,000 bacteria in each capsule). One capsule X2/day.” NCT00506181 ↗